about
Molecular Pathways Bridging Frontotemporal Lobar Degeneration and Psychiatric DisordersClinical review. Frontotemporal dementiaProgranulin: at the interface of neurodegenerative and metabolic diseasesDiagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.Cognitive impairment in lacunar strokes: the SPS3 trial.Anterior brain glucose hypometabolism predates dementia in progranulin mutation carriersProgranulin deficiency promotes post-ischemic blood-brain barrier disruptionTDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells.FTD and ALS--translating mouse studies into clinical trials.Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.The lysosomal protein cathepsin L is a progranulin protease.Association of progranulin polymorphism rs5848 with neurodegenerative diseases: a meta-analysis.Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine-rich repeat kinase 2.Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia.Longitudinal structural gray matter and white matter MRI changes in presymptomatic progranulin mutation carriers.
P2860
Q26766487-B03FD705-2F95-4CFF-AB07-C3BED5878639Q26999462-6F785C8E-837F-42FE-A240-C8C1965E3EB4Q27024421-2FC5502E-E69C-4040-9D9F-816E515230BBQ31141202-44087A0A-EAEC-456C-8EC2-EF9E960BF108Q34343910-30E92DC9-ECB8-4512-968A-2C28FA18887DQ37251668-EE65A226-D8E2-4030-A617-5E0C23A26CB8Q37381816-521B560A-AA8F-4DF8-A310-D1073A64F67BQ38326803-8A57436A-599B-4F00-B6C4-FA460747E1FDQ38457811-8154EB22-675D-4D0F-8C92-91FA944DA559Q38625515-26AE8CC2-AB52-4BAE-8152-1A0C6D18E8C5Q38661883-BE640ECA-A8E6-4BC6-8287-879448ACDB6CQ41595939-02AAEDCD-468F-427D-8AAA-DA1A9D829CBCQ42805112-4BF6BE61-FD65-41D5-8D79-0BE2BB492C78Q50888307-28584D8C-EF97-40E0-AC8E-464288B0A8D1Q55484201-BA6FF76D-A06C-4E1B-BAC7-D7B18FBC2527
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Progranulin: an emerging target for FTLD therapies.
@en
type
label
Progranulin: an emerging target for FTLD therapies.
@en
prefLabel
Progranulin: an emerging target for FTLD therapies.
@en
P2093
P2860
P1433
P1476
Progranulin: an emerging target for FTLD therapies.
@en
P2093
Caroline Stetler
Jennifer Gass
Mercedes Prudencio
P2860
P304
P356
10.1016/J.BRAINRES.2012.01.047
P407
P577
2012-01-28T00:00:00Z